Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Passage Bio Inc shares valued at $138,299 were purchased by Lynx1 Capital Management LP on Sep 12 ’25. At $6.99 per share, Lynx1 Capital Management LP acquired 19,783 shares. The insider’s holdings grew to 611,804 shares worth approximately $6.66 million following the completion of this transaction.
Also, Lynx1 Capital Management LP purchased 11,900 shares, netting a total of over 83,175 in proceeds. Following the buying of shares at $6.99 each, the insider now holds 623,704 shares.
Before that, Lynx1 Capital Management LP had added 325 shares to its account. In a trade valued at $2,261, the 10% Owner bought Passage Bio Inc shares for $6.96 each. Upon closing the transaction, the insider’s holdings increased to 325 shares, worth approximately $6.45 million.
Analysts at Rodman & Renshaw started covering the stock with ‘”a Buy”‘ outlook in a report released in early September. As of March 08, 2022, JP Morgan has decreased its “an Overweight” rating to a “Neutral” for PASG. Earlier on January 19, 2022, Goldman downgraded its rating. Their new recommendation was “a Neutral” for PASG stock which previously was a “a Buy”.
Analyzing PASG Stock Performance
On last trading session, Passage Bio Inc [NASDAQ: PASG] rose 8.74% to $10.89. The stock’s lowest price that day was $9.7287, but it reached a high of $11.26 in the same session. During the last five days, there has been a surge of approximately 20.87%. Over the course of the year, Passage Bio Inc shares have dropped approximately -17.50%. Shares of the company reached a 52-week high of $20.20 on 01/02/25 and a 52-week low of $5.12 on 07/21/25.
Support And Resistance Levels for Passage Bio Inc (PASG)
According to the 24-hour chart, there is a support level at 9.97, which, if violated, would cause prices to drop to 9.05. In the upper region, resistance lies at 11.56. The next price resistance is at 12.24. RSI (Relative Strength Index) is 64.59 on the 14-day chart, showing neutral technical sentiment.
Is Passage Bio Inc subject to short interest?
Stocks of Passage Bio Inc saw a sharp steep in short interest on 2025-11-28 dropping by 65059.0 shares to 17706.0. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 82765.0 shares. A decline of -367.44% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.44 of the overall float, the days-to-cover ratio (short ratio) decline to 0.44.
Which companies own the most shares of Passage Bio Inc (PASG)?
In terms of Passage Bio Inc share price expectations, FactSet research, analysts set an average price target of 6 in the next 12 months, down nearly -40.12% from the previous closing price of $10.02. Analysts anticipate Passage Bio Inc stock to reach 6 by 2025, with the lowest price target being 6. In spite of this, 4 analysts ranked Passage Bio Inc stock as Buy at the end of 2025. On July 01, 2021, Raymond James assigned a price target of “an Outperform” to the stock and initiated coverage with a $29.
